Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benjamin T Dake Insider Profile
4 Followers
Benjamin T Dake, President, COO and Secretary at Aerovate Therapeutics, holds 14.25K shares in Aerovate Therapeutics (Ticker: AVTE).
Benjamin T Dake has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Benjamin T Dake's holdings
Insider Roles
President, COO and Secretary
Roles that Benjamin T Dake holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Benjamin T Dake
Benjamin T Dake's Trading History
List of latest transactions for each holding click on a transaction to see Benjamin T Dake's performance on stock
You May Also Like
Benjamin T Dake insider profile FAQ
What is the percentage of profitable transactions made by Benjamin T Dake?
The percentage of profitable transactions made by Benjamin T Dake is ―.
What is the average return per transaction made by Benjamin T Dake?
The average return per transaction made by Benjamin T Dake is ―.
What stocks does Benjamin T Dake hold?
Benjamin T Dake holds: AVTE stocks.
What was Benjamin T Dake’s latest transaction?
Benjamin T Dake latest transaction was an Uninformative Buy of $22.55K.
What was Benjamin T Dake's most profitable transaction?
Benjamin T Dake’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Benjamin T Dake's role in Aerovate Therapeutics?
Benjamin T Dake's role in Aerovate Therapeutics is President, COO and Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.